
Turn Therapeutics
Turn Therapeutics is a pharmaceutical and medical device company developing novel therapies for advanced skin and wound care. Hexagen is our multi-time FDA cleared formula indicated for advanced wound care. We are now seeking FDA approval for Hexagen as a drug candidate for eczema and onychomycosis (combined $15B+ TAM). This raise will help fund our clinical trials focused on disrupting current standards of care.
Company Overview
Turn Therapeutics is a pharmaceutical and medical device company developing novel therapies for advanced skin and wound care.
Hexagen is our multi-time FDA cleared formula indicated for advanced wound care. We are now seeking FDA approval for Hexagen as a drug candidate for eczema and onychomycosis (combined $15B+ TAM). This raise will help fund our clinical trials focused on disrupting current standards of care.
Products & Services
PermaFusion®
PermaFusion® revolutionizes topical delivery through our patented mixing process which permanently fuses liquid with oil, allowing us to reduce active ingredients in our drugs without compromising performance. Less active ingredient means less potential for side effects.
Stay in the Loop
Get updates from Turn Therapeutics
Get exclusive updates from Turn Therapeutics
Be the first to know about company milestones, news, and opportunities.
🔒 No spam. Just real progress.
Company Stats
Key metrics about Turn Therapeutics
Fuel Level
Engagement metrics for Turn Therapeutics
Fuel represents engagement and interest in this company from the Crowdigy community.
Are you the owner of Turn Therapeutics?
Claim your company profile to respond to reviews, update your information, and connect with investors.
Claim This Company